ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

OCX Oncocyte Corporation

2.54
0.06 (2.42%)
시간외 거래
최종 업데이트: 08:31:09
15분 지연
기업명 주식 심볼 시장 주식 타입
Oncocyte Corporation OCX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.06 2.42% 2.54 08:31:09
개장가 저가 고가 종가 전일 종가
2.47 2.39 2.56 2.525 2.48
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
12/04/202419:00GLOBEOncocyte Reports Full Year 2023 Financial Results
12/04/202410:46GLOBEOncocyte Corporation Announces $15.8 Million Private..
12/04/202406:30GLOBEOncocyte and Bio-Rad Partner on Global Launch of Transplant..
10/04/202405:05GLOBEOncocyte to Announce Fourth Quarter and Full Year 2024..
24/01/202406:39EDGAR2Form 8-K - Current report
16/01/202422:00GLOBEOncocyte to Present at the Sequire Investor Summit in Puerto..
06/12/202322:00GLOBEOncocyte Begins FDA Submissions Process for VitaGraft..
10/11/202307:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:05EDGAR2Form 8-K - Current report
09/11/202321:00GLOBEOncocyte Reports Third Quarter 2023 Financial Results
03/11/202321:30GLOBEOncocyte to Announce Third Quarter 2023 Financial Results
13/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202305:48EDGAR2Form 8-K/A - Current report: [Amend]
06/10/202305:05EDGAR2Form 8-K - Current report
20/09/202322:00EDGAR2Form 8-K - Current report
29/08/202305:05EDGAR2Form 8-K - Current report
18/08/202307:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202305:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202320:05EDGAR2Form 8-K - Current report
25/07/202322:08GLOBEVitaGraft Kidney Expands Utility in Recurrent Primary..
25/07/202306:28EDGAR2Form 8-K - Current report
25/07/202302:35GLOBEOncocyte Announces 1-For-20 Reverse Stock Split
22/07/202306:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/07/202319:03EDGAR2Form 8-K - Current report
11/07/202300:20EDGAR2Form DEF 14A - Other definitive proxy statements
04/07/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/07/202305:14EDGAR2Form PRE 14A - Other preliminary proxy statements
30/06/202305:05EDGAR2Form 8-K - Current report
27/06/202321:30GLOBEOncocyte Begins Manufacturing Transplant Blood Test
11/05/202321:00GLOBEOncocyte Reports First Quarter 2023 Financial Results

최근 히스토리

Delayed Upgrade Clock